Stockscreener 앱 받기
2.75
1.08%
-0.03
시간 외 거래:
2.75
Puma Biotechnology Inc 주식(PBYI)의 최신 뉴스
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Acquired by Fmr LLC - Defense World
Charles Schwab Investment Management Inc. Sells 8,574 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Bought by BNP Paribas Financial Markets - Defense World
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance
Puma Biotechnology: Continuing To Push Their Aurora Kinase Story Forward - Seeking Alpha
Puma Biotechnology (NASDAQ:PBYI) Lowered to Buy Rating by StockNews.com - MarketBeat
HRMY: 3 Emerging Biotech Stocks Developing Breakthrough Therapies - StockNews.com
PBYIPUMA BIOTECHNOLOGY INC Latest Stock News & Market Updates - StockTitan
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Bakersfield Californian
Puma Biotechnology Grants 7,500-Share Inducement Award to New Employee - StockTitan
Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance
Discovering Promising US Penny Stocks In November 2024 - Simply Wall St
Puma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.com to Buy - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
Puma commences Phase II trial of alisertib for breast cancer treatment - Clinical Trials Arena
Puma Biotech Launches Phase 2 Trial for Advanced Breast Cancer Treatment | PBYI Stock News - StockTitan
245,695 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Bought by Los Angeles Capital Management LLC - MarketBeat
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance
Puma Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Puma Biotechnology reports robust Q3 growth - Investing.com
Earnings call: Puma Biotechnology reports robust Q3 growth By Investing.com - Investing.com UK
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Nasdaq
Puma Biotechnology Reports Strong Q3 2024 Growth - TipRanks
Puma Biotechnology Q3 2024 Earnings Preview - MSN
Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Puma Biotechnology Reports Third Quarter 2024 Financial Results - sharewise
Puma Biotech: Q3 Earnings Snapshot - San Francisco Chronicle
Puma Biotechnology Grants 5,625-Share Inducement Award to New Employee - StockTitan
Puma Biotechnology (NASDAQ:PBYI) Raised to "Strong-Buy" at StockNews.com - MarketBeat
Puma Biotechnology (PBYI) Set to Announce Quarterly Earnings on Thursday - MarketBeat
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ - The Bakersfield Californian
3 US Penny Stocks With Market Caps Under $700M - Simply Wall St
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - BioSpace
Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
What is Zacks Research's Forecast for PBYI FY2026 Earnings? - MarketBeat
Equities Analysts Offer Predictions for PBYI Q3 Earnings - MarketBeat
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? - Yahoo Finance
Puma Biotechnology quickly drops after patents for Tagrisso ruled invalid - MSN
FY2025 EPS Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) Decreased by Zacks Research - MarketBeat
2.88%
2.65%
자본화:
|
볼륨(24시간):